Clinical Trial Update: Studies of the Prevention of Atrial Fibrillation by ALA [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether alpha-linolenic acid (ALA) in the diet can prevent atrial fibrillation; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• ALA (alpha-linolenic acid)

Snippet

Sponsor: University of Toronto | Conditions: Atrial Fibrillation, Diet Therapy | Phase 2 | Status: UNKNOWN